LOCALIZATION OF THE VPX PACKAGING SIGNAL WITHIN THE C-TERMINUS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 GAG PRECURSOR PROTEIN

被引:67
作者
WU, XY
CONWAY, JA
KIM, J
KAPPES, JC
机构
[1] UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294
[2] UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294
关键词
D O I
10.1128/JVI.68.10.6161-6169.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Viral protein X (Vpx) is a human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus accessory protein that is packaged into virions in molar amounts equivalent to Gag proteins. To delineate the processes of virus assembly that mediate Vpx packaging, we used a recombinant vaccinia virus-T7 RNA polymerase system to facilitate Gag protein expression, particle assembly, and extracellular release. HIV genes were placed under control of the bacteriophage T7 promoter and transfected into HeLa cells expressing T7 RNA polymerase. Western immunoblot analysis detected p55(gag) and its cleavage products p39 and p27 in purified particles derived by expression of gag and gag-pol, respectively. In trans expression of vpx with either HIV-2 gag or gag-pol gave rise to virus-like particles that contained Vpx in amounts similar to that detected in HIV-2 virus produced from productively infected T cells. Using C-terminal deletion and truncation mutants of HIV-2 Gag, we mapped the p15 coding sequence for determinants of Vpx packaging. This analysis revealed a region (residues 439 to 497) downstream of the nucleocapsid protein (NC) required for incorporation of Vpx into virions. HIV-1/HIV-2 gag chimeras were constructed to further characterize the requirements for incorporation of Vpx into virions. Chimeric HTV-1/HIV-2 Gag particles consisting of HIV-1 p17 and p24 fused in frame at the C terminus with HIV-2 p15 effectively incorporate Vpx, while chimeric HIV-2/HIV-1 Gag particles consisting of HIV-2 p17 and p27 fused in frame at the C terminus with HIV-1 p15 do not. Expression of a 68 amino-acid sequence of HIV-2 containing residues 439 to 497 fused to the coding regions of HIV-1 p17 and p24 also produced virus-like particles capable of packaging Vpx in amounts similar to that of full-length HIV-2 Gag. Sucrose gradient analysis confirmed particle association of Vpx and Gag proteins. These results demonstrate that the HIV-2 Gag precursor (p55) regulates incorporation of Vpx into virions and indicates that the packaging signal is located within residues 439 to 497.
引用
收藏
页码:6161 / 6169
页数:9
相关论文
共 44 条
[21]   HIV-2 VIRAL PROTEIN-X ASSOCIATION WITH THE GAG P27 CAPSID PROTEIN [J].
HORTON, R ;
SPEARMAN, P ;
RATNER, L .
VIROLOGY, 1994, 199 (02) :453-457
[22]   DISTINCT SIGNALS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PR55 NECESSARY FOR RNA-BINDING AND PARTICLE FORMATION [J].
JOWETT, JBM ;
HOCKLEY, DJ ;
NERMUT, MV ;
JONES, IM .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :3079-3086
[23]   IDENTIFICATION OF A NOVEL RETROVIRAL GENE UNIQUE TO HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 AND SIMIAN IMMUNODEFICIENCY VIRUS SIVMAC [J].
KAPPES, JC ;
MORROW, CD ;
LEE, SW ;
JAMESON, BA ;
KENT, SBH ;
HOOD, LE ;
SHAW, GM ;
HAHN, BH .
JOURNAL OF VIROLOGY, 1988, 62 (09) :3501-3505
[24]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 VPX PROTEIN AUGMENTS VIRAL INFECTIVITY [J].
KAPPES, JC ;
CONWAY, JA ;
LEE, SW ;
SHAW, GM ;
HAHN, BH .
VIROLOGY, 1991, 184 (01) :197-209
[25]   INTRACELLULAR-TRANSPORT AND VIRION INCORPORATION OF VPX REQUIRES INTERACTION WITH OTHER VIRUS TYPE-SPECIFIC COMPONENTS [J].
KAPPES, JC ;
PARKIN, JS ;
CONWAY, JA ;
KIM, J ;
BROUILLETTE, CG ;
SHAW, GM ;
HAHN, BH .
VIROLOGY, 1993, 193 (01) :222-233
[26]   HUMAN IMMUNODEFICIENCY VIRUS-LIKE PARTICLES PRODUCED BY A VACCINIA VIRUS EXPRESSION VECTOR [J].
KARACOSTAS, V ;
NAGASHIMA, K ;
GONDA, MA ;
MOSS, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :8964-8967
[27]   MOLECULAR CHARACTERIZATION OF AN ATTENUATED HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 ISOLATE [J].
KUMAR, P ;
HUI, HX ;
KAPPES, JC ;
HAGGARTY, BS ;
HOXIE, JA ;
ARYA, SK ;
SHAW, GM ;
HAHN, BH .
JOURNAL OF VIROLOGY, 1990, 64 (02) :890-901
[28]  
LAVALLEE C, 1994, J VIROL, V68, P1926
[29]   IDENTIFICATION OF A SEQUENCE REQUIRED FOR EFFICIENT PACKAGING OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 RNA INTO VIRIONS [J].
LEVER, A ;
GOTTLINGER, H ;
HASELTINE, W ;
SODROSKI, J .
JOURNAL OF VIROLOGY, 1989, 63 (09) :4085-4087
[30]   COMPLETE NUCLEOTIDE-SEQUENCE, GENOME ORGANIZATION, AND BIOLOGICAL PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INVIVO - EVIDENCE FOR LIMITED DEFECTIVENESS AND COMPLEMENTATION [J].
LI, YX ;
HUI, HX ;
BURGESS, CJ ;
PRICE, RW ;
SHARP, PM ;
HAHN, BH ;
SHAW, GM .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6587-6600